Abstract
India and China have booming chemical, agrochemical, and pharmaceutical industries. Both countries also represent expanding markets for foreign chemical and healthcare companies. All such products require reproductive toxicity testing before marketing. The ICH testing guidelines for medicinal products are not applicable in China and India. Nonetheless, reproductive toxicity studies designed and run to ICH principles are generally acceptable for submission. The Chinese guidelines take into consideration traditional Chinese medicines, which are usually mixtures. Likewise, the specific recommendations of India and China for the reproductive toxicity testing of chemicals and pesticides differ from those of the OECD and the USEPA. Again, studies performed in accordance with internationally recognized principles are usually acceptable for submission in both countries. The Chinese guideline for the reproductive toxicity testing of agrochemicals is currently under revision; the new version is expected to resemble more closely the requirements of the OECD and the USEPA. As a member of the OECD, India has conducted Good Laboratory Practice (GLP) inspection, accreditation, and monitoring activities since 2004. China has made several attempts to join the Council Decisions on Mutual Acceptance of Data in the Assessment of Chemicals since 2005. Currently 47 laboratories in China have been certified by the national GLP authorities. Several laboratories in China have also been recently been certified by OECD member countries as GLP compliant. In India, there are currently 23 GLP-Certified laboratories; about six of these are also AALAC accredited. The specific study designs specified in the guidelines of China and India for reproductive toxicity studies are described in detail in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ICH (2005) ICH harmonised tripartite guideline detection of toxicity to reproduction for medicinal products & toxicity to male fertility S5(R2). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S5_R2/Step4/S5_R2__Guideline.pdf. Accessed 30 Jan 2012
CPCSEA (1998) Committee for the purpose of control, supervision of experiments on animals, Animal Welfare Division, Ministry of Environment and Forests, Government of India. http://moef.gov.in/divisions/awd/awd_overview.html. Accessed 29 Jan 2012
Dong L, Huang W (2010) Overview of drug evaluation system in China. Scientific Res Essays 5:514–518
Ministry of Environmental Protection of the People’s Republic of China (2010) Ministry of Environmental Protection Order 7—environmental measures on new chemical substances. MEP website http://www.mep.gov.cn/. Accessed 29 Jan 2012
Golden R, Gandy J, Vollmer G (2005) A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol 35:435–458
Pacifici GM, Nattoli R (1995) Placental transfer of drugs administered to the mother. Clin Pharmacokinet 28:235–269
Beckman DA et al (1990) Experimental manipulation of the rodent visceral yolk sac. Teratology 41:395–404
National Standard of the People’s Republic of China (1995) Toxicological test methods of pesticides for registration, GB 15670-1995. National Technology Supervision Bureau
Ministry of Health, Govt. of India (2010) The Drugs and Cosmetics Rules, 1945 (As amended vide GSR 780(E), dated 10 November 2008, w.e.f. 1 Nov 2010)
Ministry of Environmental Protection of the People’s Republic of China (2003) The guidelines for the testing of chemicals. China Environmental Science Publisher
Ministry of Health, Govt. of India (2010) The Drugs and Cosmetics Rules, 1945 (As amended vide GSR 780(E), dated 10 November 2008, w.e.f. 1 November 2010)
CDSCO (2005) Central Drugs Standard Control Organization, Ministry of Health, Govt. of India. Schedule—Y, Amendment version 2005, Drugs and Cosmetics Rules, 1945
State Food and Drug Administration of the People’s Republic of China (2006) Technical guiding principles for the reproductive toxicity of drugs. SFDA website http://www.sfda.gov.cn/. Accessed 30 Jan 2012
Takayama S et al (1995) A collaborative study in Japan on optimal treatment period and parameters for detection of male fertility disorders in rats induced by medical drugs. J Am Coll Toxicol 14:266–292
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Rao, K.S., Dong, J. (2013). Nonclinical Reproductive Toxicity Testing Requirements for Drugs, Pesticides, and Industrial Chemicals in India and China. In: Barrow, P. (eds) Teratogenicity Testing. Methods in Molecular Biology, vol 947. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-131-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-131-8_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-130-1
Online ISBN: 978-1-62703-131-8
eBook Packages: Springer Protocols